LogicBio Therapeutics Inc (NASDAQ:LOGC)
| 0.411 Delayed Data As of May 24 |  -0.0496 / -10.77%Today’s Change | 0.34 Today|||52-Week Range 5.19 | -82.21% Year-to-Date |
Latest LOGC News | Press Releases
No recent news for LogicBio Therapeutics Inc.
Today’s Trading
| Previous close | 0.46 |
| Today’s open | 0.46 |
| Day’s range | 0.41 - 0.46 |
| Volume | 5,093 |
| Average volume (3 months) | 1,071,686 |
| Market cap | $14.8M |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | +3.86% |
| Earnings growth (this year) | +21.17% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +56.63% |
| P/E ratio | NM |
| Price/Sales | 13.82 |
| Price/Book | 0.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NERVMinerva Neuroscience... | +0.01 | +3.33% |
| IMRNImmuron Ltd | 0.00 | 0.00% |
| ---- | ||
| GLMDGalmed Pharmaceutica... | -0.04 | -6.52% |
Data as of 3:51pm ET, 05/24/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $5.4M |
| Annual profit (last year) | -$40.0M |
| Net profit margin | -739.91% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
